Is switching from levetiracetam (Keppra) to valproic acid (Depakote) advisable for better mood stabilization?

Switching from Keppra to Depakote for Mood Issues

If you are experiencing mood or behavioral problems on Keppra (levetiracetam), switching to Depakote (valproic acid) is reasonable, but this decision depends critically on your clinical context—specifically whether you have epilepsy alone versus bipolar disorder, and whether you are female of childbearing potential.

Understanding the Problem

Keppra is well-documented to cause psychiatric side effects. The FDA label explicitly warns that behavioral symptoms occur in 37.6% of pediatric patients and include agitation, anxiety, depression, emotional lability, hostility, and nervousness 1. In adults, psychiatric adverse events led to hospitalization in 0.8% of patients, and behavioral/mood disorders are consistently reported across all seizure types 1.

Decision Algorithm

Step 1: Define Your Primary Diagnosis

For Epilepsy Only (No Bipolar Disorder):

• Levetiracetam remains first-line for seizure control despite psychiatric side effects 2
• The 2021 EANO-ESMO guidelines state that "levetiracetam has become the drug of first choice at most neuro-oncology centres in recent years, although psychiatric side-effects in some patients remain a concern" 2
• Before switching: Consider dose reduction of Keppra first, as this may resolve behavioral symptoms while maintaining seizure control
• If switching is necessary: Valproic acid is acceptable for seizure control with "overall good tolerability" 2, but monitor for thrombocytopenia and hepatotoxicity

For Bipolar Disorder (With or Without Epilepsy):

• Valproate is guideline-recommended for both acute mania and maintenance treatment 3
• WHO guidelines explicitly state: "Lithium, valproate, or carbamazepine should be offered to individuals with bipolar mania" and "Lithium or valproate should be used for the maintenance treatment of bipolar disorder" 3
• This makes valproate the logical choice when you need both seizure control AND mood stabilization

Step 2: Critical Safety Screening

Absolute contraindication to valproate:

• Females who may become pregnant 2
• The guidelines are unequivocal: "Valproic acid must not be used in females who may become pregnant" 2

Relative concerns with valproate:

• Risk of thrombocytopenia and hepatotoxicity requiring regular monitoring 2
• Drug interactions—check all concurrent medications 2
• Higher risk of grade 3-4 hematologic toxicity when combined with temozolomide (if applicable) 4

Step 3: Monitoring Requirements

If switching to valproate:

• Baseline: liver function tests, complete blood count, pregnancy test 5
• Ongoing: serum drug levels, hepatic and hematological indices every 3-6 months 5
• Watch for presenting symptoms of adverse effects between monitoring intervals 5

The Nuance: Context Matters

The evidence reveals an important divergence:

• For epilepsy management alone: Levetiracetam is preferred despite psychiatric side effects because of fewer drug interactions and no need for routine lab monitoring 2, 4, 6

• For mood stabilization in bipolar disorder: Valproate has established efficacy with guideline support 3

• For epilepsy WITH significant mood symptoms: The choice becomes more nuanced. While Keppra's psychiatric effects are problematic, valproate's safety profile (especially hepatotoxicity, thrombocytopenia, and teratogenicity) must be weighed against the benefit

Common Pitfalls to Avoid

1. Don't switch abruptly—taper antiepileptic drugs gradually to minimize seizure risk 1

2. Don't assume valproate is "safer" for mood—it has serious adverse effects requiring monitoring that Keppra does not 2, 5

3. Don't use valproate in women of childbearing potential without explicit contraception counseling 2

4. Don't forget that behavioral symptoms from Keppra may resolve with dose reduction before requiring a complete switch 1

Bottom Line

Switch to Depakote if: You have bipolar disorder requiring mood stabilization, you are male or a female with no pregnancy potential, and you can commit to regular lab monitoring.

Stay on Keppra (possibly at lower dose) if: You have epilepsy only, the psychiatric symptoms are mild-moderate, or you are female of childbearing potential.

Consider alternatives (lamotrigine, lacosamide) if: You need seizure control, have mood concerns, but cannot use valproate due to safety concerns 2.